Omaxe Limited has received regulatory approval from the Real Estate Regulatory Authority (RERA) for its residential project 'Natures Home' in Bathinda, Punjab. This approval marks a significant regulatory milestone for the company's development activities in the region.

Project Details and Regulatory Compliance

The RERA approval for the 'Natures Home' project carries validity until September 30, 2030, providing the company with a substantial timeframe for project development and sales activities. This regulatory clearance ensures that the project meets all necessary compliance requirements under the Real Estate (Regulation and Development) Act.

Market Impact and Buyer Confidence

The RERA approval is expected to significantly enhance buyer trust and credibility for the project. RERA registration provides transparency in real estate transactions and offers protection to homebuyers through standardized processes and accountability measures. This regulatory backing typically translates to increased market confidence and potentially improved sales prospects for the development.

Strategic Significance

This approval reinforces Omaxe Limited's commitment to regulatory compliance and transparent business practices in the real estate sector. The company's ability to secure RERA approval demonstrates its adherence to industry standards and regulatory requirements, which is crucial for maintaining its market position in the competitive real estate landscape.

Omaxe Limited has scheduled a Board of Directors meeting for February 6, 2026, to consider and approve the company's unaudited financial results for the third quarter of fiscal year 2026. The announcement was made through a regulatory filing dated January 30, 2026, addressed to both BSE Limited and National Stock Exchange of India Limited.

Meeting Details and Agenda

The Board meeting is scheduled for Friday, February 6, 2026, with the primary agenda being the consideration and approval of unaudited financial results for the quarter and nine months ended December 31, 2025. The results will include both standalone and consolidated financial statements of the company.

Trading Window Closure

In accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct for Prevention of Insider Trading, Omaxe has implemented a trading window closure. The trading window for dealing in equity shares of the company closed with effect from January 1, 2026, and will remain closed until February 8, 2026.

Regulatory Compliance

The notification has been issued pursuant to Regulation 29 and other relevant regulations of SEBI LODR Regulations, 2015, as amended. The company has ensured compliance with BSE and NSE clarifications issued through respective circulars regarding trading window closures during financial results announcements.

Company Information

The filing was signed by D B R Srikanta, Company Secretary and Compliance Officer of Omaxe Limited. The notice is available on the company's website at www.omaxe.com and on the stock exchange websites. Omaxe Limited operates from its corporate office located at 7, Local Shopping Centre, Kalkaji, New Delhi-110019, with its registered office situated in Gurgaon, Haryana.